Table of Contents 1 Study Coverage 1.1 Nuclear Medicine/Radiopharmaceutic Product 1.2 Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Nuclear Medicine/Radiopharmaceutic Market Size Growth Rate by Product 1.4.2 Diagnostic 1.4.3 Therapeutic 1.5 Market by End User 1.5.1 Global Nuclear Medicine/Radiopharmaceutic Market Size Growth Rate by End User 1.5.2 Oncology 1.5.3 Thyroid 1.5.4 Cardiology 1.5.5 Others 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Nuclear Medicine/Radiopharmaceutic Market Size 2.1.1 Global Nuclear Medicine/Radiopharmaceutic Revenue 2014-2025 2.1.2 Global Nuclear Medicine/Radiopharmaceutic Sales 2014-2025 2.2 Nuclear Medicine/Radiopharmaceutic Growth Rate by Regions 2.2.1 Global Nuclear Medicine/Radiopharmaceutic Sales by Regions 2.2.2 Global Nuclear Medicine/Radiopharmaceutic Revenue by Regions 3 Breakdown Data by Manufacturers 3.1 Nuclear Medicine/Radiopharmaceutic Sales by Manufacturers 3.1.1 Nuclear Medicine/Radiopharmaceutic Sales by Manufacturers 3.1.2 Nuclear Medicine/Radiopharmaceutic Sales Market Share by Manufacturers 3.1.3 Global Nuclear Medicine/Radiopharmaceutic Market Concentration Ratio (CR5 and HHI) 3.2 Nuclear Medicine/Radiopharmaceutic Revenue by Manufacturers 3.2.1 Nuclear Medicine/Radiopharmaceutic Revenue by Manufacturers (2014-2019) 3.2.2 Nuclear Medicine/Radiopharmaceutic Revenue Share by Manufacturers (2014-2019) 3.3 Nuclear Medicine/Radiopharmaceutic Price by Manufacturers 3.4 Nuclear Medicine/Radiopharmaceutic Manufacturing Base Distribution, Product Types 3.4.1 Nuclear Medicine/Radiopharmaceutic Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Nuclear Medicine/Radiopharmaceutic Product Type 3.4.3 Date of International Manufacturers Enter into Nuclear Medicine/Radiopharmaceutic Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Product 4.1 Global Nuclear Medicine/Radiopharmaceutic Sales by Product 4.2 Global Nuclear Medicine/Radiopharmaceutic Revenue by Product 4.3 Nuclear Medicine/Radiopharmaceutic Price by Product 5 Breakdown Data by End User 5.1 Overview 5.2 Global Nuclear Medicine/Radiopharmaceutic Breakdown Data by End User 6 North America 6.1 North America Nuclear Medicine/Radiopharmaceutic by Countries 6.1.1 North America Nuclear Medicine/Radiopharmaceutic Sales by Countries 6.1.2 North America Nuclear Medicine/Radiopharmaceutic Revenue by Countries 6.1.3 United States 6.1.4 Canada 6.1.5 Mexico 6.2 North America Nuclear Medicine/Radiopharmaceutic by Product 6.3 North America Nuclear Medicine/Radiopharmaceutic by End User 7 Europe 7.1 Europe Nuclear Medicine/Radiopharmaceutic by Countries 7.1.1 Europe Nuclear Medicine/Radiopharmaceutic Sales by Countries 7.1.2 Europe Nuclear Medicine/Radiopharmaceutic Revenue by Countries 7.1.3 Germany 7.1.4 France 7.1.5 UK 7.1.6 Italy 7.1.7 Russia 7.2 Europe Nuclear Medicine/Radiopharmaceutic by Product 7.3 Europe Nuclear Medicine/Radiopharmaceutic by End User 8 Asia Pacific 8.1 Asia Pacific Nuclear Medicine/Radiopharmaceutic by Countries 8.1.1 Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales by Countries 8.1.2 Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue by Countries 8.1.3 China 8.1.4 Japan 8.1.5 Korea 8.1.6 India 8.1.7 Australia 8.1.8 Indonesia 8.1.9 Malaysia 8.1.10 Philippines 8.1.11 Thailand 8.1.12 Vietnam 8.1.13 Singapore 8.2 Asia Pacific Nuclear Medicine/Radiopharmaceutic by Product 8.3 Asia Pacific Nuclear Medicine/Radiopharmaceutic by End User 9 Central & South America 9.1 Central & South America Nuclear Medicine/Radiopharmaceutic by Countries 9.1.1 Central & South America Nuclear Medicine/Radiopharmaceutic Sales by Countries 9.1.2 Central & South America Nuclear Medicine/Radiopharmaceutic Revenue by Countries 9.1.3 Brazil 9.2 Central & South America Nuclear Medicine/Radiopharmaceutic by Product 9.3 Central & South America Nuclear Medicine/Radiopharmaceutic by End User 10 Middle East and Africa 10.1 Middle East and Africa Nuclear Medicine/Radiopharmaceutic by Countries 10.1.1 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales by Countries 10.1.2 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue by Countries 10.1.3 GCC Countries 10.1.4 Turkey 10.1.5 Egypt 10.1.6 South Africa 10.2 Middle East and Africa Nuclear Medicine/Radiopharmaceutic by Product 10.3 Middle East and Africa Nuclear Medicine/Radiopharmaceutic by End User 11 Company Profiles 11.1 China Isotope Radiation 11.1.1 China Isotope Radiation Company Details 11.1.2 Company Business Overview 11.1.3 China Isotope Radiation Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2014-2019) 11.1.4 China Isotope Radiation Nuclear Medicine/Radiopharmaceutic Products Offered 11.1.5 China Isotope Radiation Recent Development 11.2 Dongcheng 11.2.1 Dongcheng Company Details 11.2.2 Company Business Overview 11.2.3 Dongcheng Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2014-2019) 11.2.4 Dongcheng Nuclear Medicine/Radiopharmaceutic Products Offered 11.2.5 Dongcheng Recent Development 11.3 Jaco 11.3.1 Jaco Company Details 11.3.2 Company Business Overview 11.3.3 Jaco Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2014-2019) 11.3.4 Jaco Nuclear Medicine/Radiopharmaceutic Products Offered 11.3.5 Jaco Recent Development 11.4 Ciaeriar 11.4.1 Ciaeriar Company Details 11.4.2 Company Business Overview 11.4.3 Ciaeriar Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2014-2019) 11.4.4 Ciaeriar Nuclear Medicine/Radiopharmaceutic Products Offered 11.4.5 Ciaeriar Recent Development 11.5 Advanced Molecular-imaging Solution 11.5.1 Advanced Molecular-imaging Solution Company Details 11.5.2 Company Business Overview 11.5.3 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2014-2019) 11.5.4 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceutic Products Offered 11.5.5 Advanced Molecular-imaging Solution Recent Development 11.6 Shanghai Atom Kexing 11.6.1 Shanghai Atom Kexing Company Details 11.6.2 Company Business Overview 11.6.3 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2014-2019) 11.6.4 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceutic Products Offered 11.6.5 Shanghai Atom Kexing Recent Development 11.7 Cardinal Health 11.7.1 Cardinal Health Company Details 11.7.2 Company Business Overview 11.7.3 Cardinal Health Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2014-2019) 11.7.4 Cardinal Health Nuclear Medicine/Radiopharmaceutic Products Offered 11.7.5 Cardinal Health Recent Development 11.8 Mallinckrodt 11.8.1 Mallinckrodt Company Details 11.8.2 Company Business Overview 11.8.3 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2014-2019) 11.8.4 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Products Offered 11.8.5 Mallinckrodt Recent Development 11.9 GE Healthcare 11.9.1 GE Healthcare Company Details 11.9.2 Company Business Overview 11.9.3 GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2014-2019) 11.9.4 GE Healthcare Nuclear Medicine/Radiopharmaceutic Products Offered 11.9.5 GE Healthcare Recent Development 11.10 Lantheus Medical Imaging 11.10.1 Lantheus Medical Imaging Company Details 11.10.2 Company Business Overview 11.10.3 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2014-2019) 11.10.4 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Products Offered 11.10.5 Lantheus Medical Imaging Recent Development 11.11 Bayer Healthcare 11.12 Bracco Imaging 11.13 Eczacibasi-Monrol Nuclear Products 11.14 Nordion 11.15 Advanced Accelerator Applications 11.16 Iba Molecular Imaging 12 Future Forecast 12.1 Nuclear Medicine/Radiopharmaceutic Market Forecast by Regions 12.1.1 Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Regions 2019-2025 12.1.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Regions 2019-2025 12.2 Nuclear Medicine/Radiopharmaceutic Market Forecast by Product 12.2.1 Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Product 2019-2025 12.2.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Product 2019-2025 12.3 Nuclear Medicine/Radiopharmaceutic Market Forecast by End User 12.4 North America Nuclear Medicine/Radiopharmaceutic Forecast 12.5 Europe Nuclear Medicine/Radiopharmaceutic Forecast 12.6 Asia Pacific Nuclear Medicine/Radiopharmaceutic Forecast 12.7 Central & South America Nuclear Medicine/Radiopharmaceutic Forecast 12.8 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Forecast 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Macroscopic Indicators 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Nuclear Medicine/Radiopharmaceutic Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables and Figures Figure Nuclear Medicine/Radiopharmaceutic Product Picture Table Nuclear Medicine/Radiopharmaceutic Market Segments Table Key Manufacturers Nuclear Medicine/Radiopharmaceutic Covered Table Global Nuclear Medicine/Radiopharmaceutic Market Size Growth Rate by Product 2019-2025 (MT) & (Million US$) Figure Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Product 2014-2025 Figure Diagnostic Product Picture Table Major Manufacturers of Diagnostic Figure Therapeutic Product Picture Table Major Manufacturers of Therapeutic Table Global Nuclear Medicine/Radiopharmaceutic Market Size Growth Rate by End User 2019-2025 (MT) Figure Oncology Figure Thyroid Figure Cardiology Figure Others Figure Nuclear Medicine/Radiopharmaceutic Report Years Considered Figure Global Nuclear Medicine/Radiopharmaceutic Market Size 2014-2025 (Million US$) Figure Global Nuclear Medicine/Radiopharmaceutic Sales 2014-2025 (MT) Table Global Nuclear Medicine/Radiopharmaceutic Market Size by Regions 2014-2019 (MT) & (Million US$) Table Global Nuclear Medicine/Radiopharmaceutic Sales by Regions 2014-2019 (MT) Table Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Regions 2014-2019 Figure Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Regions 2014-2019 Figure 2018 Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Regions Table Global Nuclear Medicine/Radiopharmaceutic Revenue by Regions 2014-2019 (Million US$) Table Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Regions 2014-2019 Figure Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Regions 2014-2019 Figure 2018 Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Regions Table Global Nuclear Medicine/Radiopharmaceutic Sales by Manufacturers (2014-2019) (MT) Table Global Nuclear Medicine/Radiopharmaceutic Sales Share by Manufacturers (2014-2019) Figure Global Nuclear Medicine/Radiopharmaceutic Sales Share by Manufacturers in 2018 Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Nuclear Medicine/Radiopharmaceutic Revenue by Manufacturers (2014-2019) (Million USD) Table Nuclear Medicine/Radiopharmaceutic Revenue Share by Manufacturers (2014-2019) Figure Nuclear Medicine/Radiopharmaceutic Value Share by Manufacturers in 2018 Table Key Manufacturers Nuclear Medicine/Radiopharmaceutic Price (2014-2019) (USD/Kg) Table Nuclear Medicine/Radiopharmaceutic Manufacturers Manufacturing Base Distribution and Headquarters Table Manufacturers Nuclear Medicine/Radiopharmaceutic Product Type Table Date of International Manufacturers Enter into Nuclear Medicine/Radiopharmaceutic Market Table Manufacturers Mergers & Acquisitions, Expansion Plans Table Global Nuclear Medicine/Radiopharmaceutic Sales by Product (2014-2019) (MT) Table Global Nuclear Medicine/Radiopharmaceutic Sales Share by Product (2014-2019) Figure Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Product (2014-2019) Figure Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Product in 2018 Table Global Nuclear Medicine/Radiopharmaceutic Revenue by Product (2014-2019) (Million US$) Table Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Product (2014-2019) Figure Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Product (2014-2019) Figure Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Product in 2018 Table Nuclear Medicine/Radiopharmaceutic Price by Product 2014-2019 (USD/Kg) Table Global Nuclear Medicine/Radiopharmaceutic Sales by End User (2014-2019) (MT) Table Global Nuclear Medicine/Radiopharmaceutic Sales Share by End User (2014-2019) Figure Global Sales Nuclear Medicine/Radiopharmaceutic Market Share by End User (2014-2019) Figure Global Sales Nuclear Medicine/Radiopharmaceutic Market Share by End User in 2018 Figure North America Nuclear Medicine/Radiopharmaceutic Sales Growth Rate 2014-2019 (MT) Figure North America Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate 2014-2019 (Million US$) Table North America Nuclear Medicine/Radiopharmaceutic Sales by Countries (2014-2019) (MT) Table North America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries (2014-2019) Figure 2018 North America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries Table North America Nuclear Medicine/Radiopharmaceutic Revenue by Countries (2014-2019) (Million US$) Table North America Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries (2014-2019) Figure 2018 North America Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries Figure United States Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT) Figure United States Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (MT) Figure Canada Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT) Figure Canada Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$) Figure Mexico Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT) Figure Mexico Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$) Table North America Nuclear Medicine/Radiopharmaceutic Sales by Product (2014-2019) (MT) Table North America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Product (2014-2019) Figure 2018 North America Nuclear Medicine/Radiopharmaceutic Market Share by Product Table North America Nuclear Medicine/Radiopharmaceutic Sales by End User (2014-2019) (MT) Table North America Nuclear Medicine/Radiopharmaceutic Sales Market Share by End User (2014-2019) Figure 2018 North America Nuclear Medicine/Radiopharmaceutic Market Share by End User Figure Europe Nuclear Medicine/Radiopharmaceutic Sales Growth Rate 2014-2019 (MT) Figure Europe Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate 2014-2019 (Million US$) Table Europe Nuclear Medicine/Radiopharmaceutic Sales by Countries (2014-2019) (MT) Table Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries (2014-2019) Figure 2018 Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries Table Europe Nuclear Medicine/Radiopharmaceutic Revenue by Countries (2014-2019) (Million US$) Table Europe Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries (2014-2019) Figure 2018 Europe Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries Figure Germany Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT) Figure Germany Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$) Figure France Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT) Figure France Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$) Figure UK Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT) Figure UK Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$) Figure Italy Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT) Figure Italy Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$) Figure Russia Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT) Figure Russia Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$) Table Europe Nuclear Medicine/Radiopharmaceutic Sales by Product (2014-2019) (MT) Table Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Product (2014-2019) Figure 2018 Europe Nuclear Medicine/Radiopharmaceutic Market Share by Product Table Europe Nuclear Medicine/Radiopharmaceutic Sales by End User (2014-2019) (MT) Table Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by End User (2014-2019) Figure 2018 Europe Nuclear Medicine/Radiopharmaceutic Market Share by End User Figure Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales Growth Rate 2014-2019 (MT) Figure Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate 2014-2019 (Million US$) Table Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales by Countries (2014-2019) (MT) Table Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries Table Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue by Countries (2014-2019) (Million US$) Table Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries Figure China Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT) Figure China Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$) Figure Japan Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT) Figure Japan Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$) Figure Korea Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT) Figure Korea Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$) Figure India Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT) Figure India Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$) Figure Australia Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT) Figure Australia Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$) Figure Indonesia Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT) Figure Indonesia Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$) Figure Malaysia Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT) Figure Malaysia Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$) Figure Philippines Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT) Figure Philippines Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$) Figure Thailand Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT) Figure Thailand Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$) Figure Vietnam Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT) Figure Vietnam Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$) Figure Singapore Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT) Figure Singapore Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$) Table Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales by Product (2014-2019) (MT) Table Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share by Product (2014-2019) Figure 2018 Asia Pacific Nuclear Medicine/Radiopharmaceutic Market Share by Product Table Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales by End User (2014-2019) (MT) Table Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share by End User (2014-2019) Figure 2018 Asia Pacific Nuclear Medicine/Radiopharmaceutic Market Share by End User Figure Central & South America Nuclear Medicine/Radiopharmaceutic Sales Growth Rate 2014-2019 (MT) Figure Central & South America Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate 2014-2019 (Million US$) Table Central & South America Nuclear Medicine/Radiopharmaceutic Sales by Countries (2014-2019) (MT) Table Central & South America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries (2014-2019) Figure 2018 Central & South America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries Table Central & South America Nuclear Medicine/Radiopharmaceutic Revenue by Countries (2014-2019) (Million US$) Table Central & South America Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries (2014-2019) Figure 2018 Central & South America Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries Figure Brazil Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT) Figure Brazil Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$) Figure Argentina Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT) Figure Argentina Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$) Table Central & South America Nuclear Medicine/Radiopharmaceutic Sales by Product (2014-2019) (MT) Table Central & South America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Product (2014-2019) Figure 2018 Central & South America Nuclear Medicine/Radiopharmaceutic Market Share by Product Table Central & South America Nuclear Medicine/Radiopharmaceutic Sales by End User (2014-2019) (MT) Table Central & South America Nuclear Medicine/Radiopharmaceutic Sales Market Share by End User (2014-2019) Figure 2018 Central & South America Nuclear Medicine/Radiopharmaceutic Market Share by End User Figure Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales Growth Rate 2014-2019 (MT) Figure Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate 2014-2019 (Million US$) Table Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales by Countries (2014-2019) (MT) Table Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries Table Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue by Countries (2014-2019) (Million US$) Table Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries Figure GCC Countries Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT) Figure GCC Countries Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$) Figure Turkey Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT) Figure Turkey Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$) Figure Egypt Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT) Figure Egypt Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$) Figure South Africa Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT) Figure South Africa Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$) Table Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales by Product (2014-2019) (MT) Table Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Product (2014-2019) Figure 2018 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Market Share by Product Table Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales by End User (2014-2019) (MT) Table Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by End User (2014-2019) Figure 2018 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Market Share by End User Table China Isotope Radiation Company Details Table China Isotope Radiation Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019) Table China Isotope Radiation Recent Development Table Dongcheng Company Details Table Dongcheng Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019) Table Dongcheng Recent Development Table Jaco Company Details Table Jaco Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019) Table Jaco Recent Development Table Ciaeriar Company Details Table Ciaeriar Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019) Table Ciaeriar Recent Development Table Advanced Molecular-imaging Solution Company Details Table Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019) Table Advanced Molecular-imaging Solution Recent Development Table Shanghai Atom Kexing Company Details Table Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019) Table Shanghai Atom Kexing Recent Development Table Cardinal Health Company Details Table Cardinal Health Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019) Table Cardinal Health Recent Development Table Mallinckrodt Company Details Table Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019) Table Mallinckrodt Recent Development Table GE Healthcare Company Details Table GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019) Table GE Healthcare Recent Development Table Lantheus Medical Imaging Company Details Table Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019) Table Lantheus Medical Imaging Recent Development Table Bayer Healthcare Company Details Table Bracco Imaging Company Details Table Eczacibasi-Monrol Nuclear Products Company Details Table Nordion Company Details Table Advanced Accelerator Applications Company Details Table Iba Molecular Imaging Company Details Table Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Regions 2019-2025 (MT) Table Global Nuclear Medicine/Radiopharmaceutic Sales Market Share Forecast by Regions 2019-2025 Table Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Regions 2019-2025 (Million US$) Table Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share Forecast by Regions 2019-2025 Table Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Product 2019-2025 (MT) Table Global Nuclear Medicine/Radiopharmaceutic Sales Market Share Forecast by Product 2019-2025 Table Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Product 2019-2025 (Million US$) Table Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share Forecast by Product 2019-2025 Table Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by End User 2019-2025 (MT) Table Global Nuclear Medicine/Radiopharmaceutic Sales Market Share Forecast by End User 2019-2025 Figure North America Nuclear Medicine/Radiopharmaceutic Sales Growth Rate Forecast (2019-2025) (MT) Figure North America Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Europe Nuclear Medicine/Radiopharmaceutic Sales Growth Rate Forecast (2019-2025) (MT) Figure Europe Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales Growth Rate Forecast (2019-2025) (MT) Figure Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Central & South America Nuclear Medicine/Radiopharmaceutic Sales Growth Rate Forecast (2019-2025) (MT) Figure Central & South America Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales Growth Rate Forecast (2019-2025) (MT) Figure Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate Forecast (2019-2025) (Million US$) Table Nuclear Medicine/Radiopharmaceutic Value Chain Table Nuclear Medicine/Radiopharmaceutic Customers List Table Nuclear Medicine/Radiopharmaceutic Distributors List Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

China Isotope Radiation Dongcheng Jaco Ciaeriar Advanced Molecular-imaging Solution Shanghai Atom Kexing Cardinal Health Mallinckrodt GE Healthcare Lantheus Medical Imaging Bayer Healthcare Bracco Imaging Eczacibasi-Monrol Nuclear Products Nordion Advanced Accelerator Applications Iba Molecular Imaging